{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:01:16Z","timestamp":1790197276872,"version":"4.1.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GA CR","award":["P301\/12\/1734"],"award-info":[{"award-number":["P301\/12\/1734"]}]},{"name":"GAUK","award":["620612"],"award-info":[{"award-number":["620612"]}]},{"name":"GAUK","award":["635712\/2012"],"award-info":[{"award-number":["635712\/2012"]}]},{"name":"Ministry of Health of the Czech Republic for conceptual development of research organization","award":["00064203"],"award-info":[{"award-number":["00064203"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162916","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T17:46:14Z","timestamp":1473875174000},"page":"e0162916","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma"],"prefix":"10.1371","volume":"11","author":[{"given":"Mohamed Ashraf","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hrab\u011bta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Proch\u00e1zka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Doktorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Eckschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"S Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"M Grunstein","year":"1997","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8935-6-11","article-title":"The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing","volume":"6","author":"E Boudadi","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","article-title":"Valproic acid in the complex therapy of malignant tumors","volume":"11","author":"J Hrebackova","year":"2010","journal-title":"Curr Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma","volume":"21","author":"H-Z Lee","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/jpet.106.106658","article-title":"Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells","volume":"319","author":"CL Chen","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","article-title":"Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells","volume":"92","author":"M-T Stockhausen","year":"2005","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/jcp.22679","article-title":"The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells","volume":"226","author":"G Shi","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"184154","DOI":"10.1155\/2012\/184154","article-title":"Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming","volume":"2012","author":"A Kretsovali","year":"2012","journal-title":"Stem Cells Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/labinvest.2014.132","article-title":"Generation of pluripotent stem cells without the use of genetic material","volume":"95","author":"A Higuchi","year":"2015","journal-title":"Lab Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"L De Felice","year":"2005","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e22158","DOI":"10.1371\/journal.pone.0022158","article-title":"Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cells","volume":"6","author":"I Burba","year":"2011","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/19336918.2015.1112486","article-title":"Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail","volume":"9","author":"J Feng","year":"2015","journal-title":"Cell Adh Migr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/cr.2008.270","article-title":"Promoter hypomethylation regulates CD133 expression in human gliomas","volume":"18","author":"K Tabu","year":"2008","journal-title":"Cell Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"T Reya","year":"2001","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/pr.2011.54","article-title":"Role of stemness-related molecules in neuroblastoma","volume":"71","author":"T Kamijo","year":"2012","journal-title":"Pediatr Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nn1473","article-title":"Isolation of neural stem cells from the postnatal cerebellum","volume":"8","author":"A Lee","year":"2005","journal-title":"Nat Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"SK Singh","year":"2004","journal-title":"Nature"},{"key":"ref19","first-page":"563","article-title":"CD133: to be or not to be, is this the real question?","volume":"5","author":"E Irollo","year":"2013","journal-title":"Am J Transl Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"T Baba","year":"2009","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1158\/0008-5472.CAN-07-6208","article-title":"Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors","volume":"68","author":"JM Yi","year":"2008","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.biocel.2004.08.010","article-title":"AC133\/CD133\/Prominin-1","volume":"37","author":"V Shmelkov S","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1038\/cddis.2011.80","article-title":"Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions","volume":"2","author":"JD Lathia","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.22476","article-title":"CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity","volume":"120","author":"S Yin","year":"2007","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e3469","DOI":"10.1371\/journal.pone.0003469","article-title":"Detection and characterization of CD133+ cancer stem cells in human solid tumours","volume":"3","author":"V Tirino","year":"2008","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/stem.1317","article-title":"CD133 is essential for glioblastoma stem cell maintenance","volume":"31","author":"P Brescia","year":"2013","journal-title":"Stem Cells"},{"key":"ref27","first-page":"1279","article-title":"Cooperation of side population cells with CD133 to enrich cancer stem cells in a laryngeal cancer cell line","volume":"36","author":"CP Wu","year":"2013","journal-title":"Head Neck"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22351","article-title":"Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents","volume":"54","author":"SD Vangipuram","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e53710","DOI":"10.1371\/journal.pone.0053710","article-title":"The Cancer Stem Cell Marker CD133 Interacts with Plakoglobin and Controls Desmoglein-2 Protein Levels","volume":"8","author":"R Koyama-Nasu","year":"2013","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"CA O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4","volume":"1","author":"M Todaro","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1073\/pnas.1217002110","article-title":"Activation of PI3K\/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells","volume":"110","author":"Y Wei","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-06-2201","article-title":"Activation of Akt predicts poor outcome in neuroblastoma","volume":"67","author":"D Opel","year":"2007","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/cr.2011.38","article-title":"Oct-4+\/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells","volume":"21","author":"A Pezzolo","year":"2011","journal-title":"Cell Res"},{"key":"ref35","first-page":"58","article-title":"Expression and clinical significance of stem cell marker CD133 in human neuroblastoma","volume":"4","author":"Q-S Tong","year":"2008","journal-title":"WJP"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-2559.2012.04191.x","article-title":"CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway","volume":"60","author":"H Sartelet","year":"2012","journal-title":"Histopathology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.2597","article-title":"The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer","volume":"219","author":"D Horst","year":"2009","journal-title":"J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11060-013-1234-z","article-title":"Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas","volume":"115","author":"JH Shin","year":"2013","journal-title":"J Neurooncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"G Liu","year":"2006","journal-title":"Mol Cancer"},{"issue":"Suppl","key":"ref40","first-page":"9","article-title":"Differentiation arrest in neuroblastoma cell culture","volume":"116","author":"J Cinatl","year":"1990","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones","volume":"2","author":"D Shechter","year":"2007","journal-title":"Nat Protoc"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3892\/ijo.2015.2996","article-title":"The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells","volume":"47","author":"T Groh","year":"2015","journal-title":"Int J Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2003-06-1881","article-title":"Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133","volume":"103","author":"SV Shmelkov","year":"2004","journal-title":"Blood"},{"issue":"Suppl 3","key":"ref44","first-page":"16","article-title":"Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells","volume":"33","author":"T Groh","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00280-014-2384-1","article-title":"Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers","volume":"73","author":"JJ Wheler","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4149\/neo_2012_093","article-title":"Neuroblastoma stem cells\u2014Mechanisms of chemoresistance and histonedeacetylase inhibitors","author":"MA Khalil","year":"2012","journal-title":"Neoplasma"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"CJ Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the Use of SH\u2014SY5Y Neuroblastoma Cells in Neurobiology","volume":"1078","author":"J Kovalevich","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3892\/or.2014.2999","article-title":"Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells","volume":"31","author":"J Poljakov\u00e1","year":"2014","journal-title":"Oncol Rep"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2010.06648.x","article-title":"Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase","volume":"113","author":"M Veas-Perez de Tudela","year":"2010","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1349-7006.2009.01144.x","article-title":"Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells","volume":"100","author":"X Meng","year":"2009","journal-title":"Cancer Sci"},{"key":"ref52","first-page":"2111","article-title":"CD133 expression is not restricted to stem cells, and both CD133 + and CD133- metastatic colon cancer cells initiate tumors","volume":"118","author":"SV Shmelkov","year":"2008","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/0008-5472.CAN-09-1820","article-title":"The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation","volume":"70","author":"K Kemper","year":"2010","journal-title":"Cancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e3655","DOI":"10.1371\/journal.pone.0003655","article-title":"CD133 is a marker of bioenergetic stress in human glioma","volume":"3","author":"CE Griguer","year":"2008","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e0130519","DOI":"10.1371\/journal.pone.0130519","article-title":"CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells","volume":"10","author":"A Barrantes-Freer","year":"2015","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4161\/cbt.22000","article-title":"Characterization of the conversion between CD133+and CD133\u2014cells in colon cancer SW620 cell line","volume":"13","author":"JM Feng","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/wsbm.12","article-title":"Sox2 and Oct-3\/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells","volume":"1","author":"A Rizzino","year":"2009","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e76761","DOI":"10.1371\/journal.pone.0076761","article-title":"Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor","volume":"8","author":"B H\u00e4mmerle","year":"2013","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/cas.12677","article-title":"Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas","volume":"106","author":"Y Kaneko","year":"2015","journal-title":"Cancer Sci"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3835(03)00079-X","article-title":"A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors","volume":"197","author":"RA Ross","year":"2003","journal-title":"Cancer Lett"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/cells1041045","article-title":"Regenerative Effects of Mesenchymal Stem Cells: Contribution of Muse Cells, a Novel Pluripotent Stem Cell Type that Resides in Mesenchymal Cells","volume":"1","author":"S Wakao","year":"2012","journal-title":"Cells"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.apsb.2013.02.006","article-title":"Cancer stem cells: therapeutic implications and perspectives in cancer therapy","volume":"3","author":"L Han","year":"2013","journal-title":"Acta Pharm Sin B"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e5498","DOI":"10.1371\/journal.pone.0005498","article-title":"CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent","volume":"4","author":"Y Sun","year":"2009","journal-title":"PLoS One"},{"key":"ref64","first-page":"738","article-title":"Caspase 3 in breast cancer","volume":"9","author":"N O\u2019Donovan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","article-title":"CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway","volume":"27","author":"S Ma","year":"2008","journal-title":"Oncogene"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.18632\/oncotarget.1314","article-title":"Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer","volume":"4","author":"L Ellis","year":"2013","journal-title":"Oncotarget"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:35:13Z","timestamp":1589031313000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162916"}},"subtitle":[],"editor":[{"given":"Gianpaolo","family":"Papaccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162916","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}